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Abstract
Familial recurrent hydatidiform mole (RHM) is a maternal-effect autosomal recessive disor-
der usually associated with mutations of the NLRP7 gene. It is characterized by HM with
excessive trophoblastic proliferation, which mimics the appearance of androgenetic molar
conceptuses despite their diploid biparental constitution. It has been proposed that the phe-
notypes of both types of mole are associated with aberrant genomic imprinting. However no
systematic analyses for imprinting defects have been reported. Here, we present the
genome-wide methylation profiles of both spontaneous androgenetic and biparental NLRP7
defective molar tissues. We observe total paternalization of all ubiquitous and placenta-
specific differentially methylated regions (DMRs) in four androgenetic moles; namely gain of
methylation at paternally methylated loci and absence of methylation at maternally methyl-
ated regions. The methylation defects observed in five RHM biopsies from NLRP7 defective
patients are restricted to lack-of-methylation at maternal DMRs. Surprisingly RHMs from
two sisters with the same missense mutations, as well as consecutive RHMs from one
affected female show subtle allelic methylation differences, suggesting inter-RHM variation.
These epigenotypes are consistent with NLRP7 being a maternal-effect gene and involved
in imprint acquisition in the oocyte. In addition, bioinformatic screening of the resulting
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These observations strongly suggest that the molar phenotypes are due to defective pla-
centa-specific imprinting and over-expression of paternally expressed transcripts, highlight-
ing that maternal-effect mutations of NLRP7 are associated with the most severe form of
multi-locus imprinting defects in humans.
Author Summary
Complete hydatidiform moles (CHMs) are abnormal human conceptsus characterized by
excessive trophoblast proliferation that commonly result from the absence of a maternal
genetic contribution compensated by two copies of the paternal genome. In a few rare
cases HMs maybe recurrent (RHM), characterized by a biparental genetic contribution
and underlying NLRP7mutations. It is speculated that aberrant genomic imprinting plays
a key role in HM formation, but to date no studies have determined the extent of imprint
defects in molar biopsies. By comparing the methylation profile of CHMs and RHMs with
normal placentas, we confirm widespread absence of allelic methylation at imprinted loci
and identify many aberrantly methylated regions, all of which have profiles consistent
with imprinting.
Introduction
The most common form of complete hydatidiform mole (CHM) is sporadic and androgenetic
diploid in origin. These products of conception frequently result from the fertilization of an
oocyte from which the maternal chromosomes are lost and endoreduplication of a single
sperm genome, or the fertilization by two sperm, to give a diploid DNA content of entirely
paternal origin [1]. Occasionally HM can be recurrent and familial in nature (OMIM 231090)
[2]. Detailed homozygosity mapping and gene mutation screening has identified two loci,
19q13.4 and 6q13, which harbor the causative genes, NLRP7 (NACHT, leucine rich repeat and
PYD containing 7) and KHDC3L (also known as C6ORF221) respectively [3, 4]. Approximately
70% of women affected by familial recurrent HM (RHM) are associated with recessive muta-
tions of NLRP7 [5, 6], whereas genetic aberrations of KHDC3L are much less frequent, and
present in only ~10% of patients without an NLRP7 involvement [7, 8]. In both cases the muta-
tions cause the RHM by maternal-effect. Definitive evidence that a defective oocyte is responsi-
ble for the pathophysiology of RHM comes from the observations that assisted reproductive
cycles using donated oocytes in three patients with recessive NLRP7mutations resulted in nor-
mal offspring [8, 9]. This maternal-effect model is consistent with transcript abundance of
both NLRP7 and KHDC3L, which accumulate in the developing oocytes and are present in
early pre-implantation embryos [10, 11]. Such expression profiles are coherent with an involve-
ment in the control of maternally derived epigenetic programing or early developmental events
in the zygote that occur before embryonic genome activation. Paternal transmission of NLRP7
mutations does not interfere with spermatogenesis, since males homozygous for NLRP7muta-
tions can father children [5, 12].
Epigenetic studies in these abnormal pregnancies have revealed aberrant DNAmethylation
profiles at a limited number of imprinted genes [13, 14]. Imprinted genes are expressed in a
parent-of-origin specific fashion, which is coordinated by differentially methylation regions
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(DMRs) inherited from the gametes [15]. NLRP7 does not have an orthologue in mouse, but is
thought to have originated from an evolutionary duplication of its nearest family member,
NLRP2 [16]. Curiously, mutations of NLRP2 are responsible for a single familial case of Beck-
with-Wiedemann syndrome with methylation defects at multiple loci, including KvDMR1
(also known as ICR2) andMEST DMR [17].
Consistent with their androgenetic composition, our recent genome-wide methylation pro-
filing of sporadic HMs revealed the paternalization of all known imprinted DMRs, with mater-
nally-methylated DMRs being devoid of methylation and paternally-derived DMRs being fully
methylated [18]. Similar analyses on RHM biopsies tissues with known underlying genetic
causes are difficult to conduct, partially hampered by the fact that genetic diagnosis takes place
in the phenotypically normal affected women, with the molar tissues discarded following path-
ological examination.
Results
DNAmethylation profiling of ubiquitous imprinted DMRs in NLRP7
mutated RHMs
In this study, we determine the genome-wide methylation profiles of RHMs from four females
with NLRP7mutations using the high-density Illumina Infinium HumanMethylation450
(HM450k) BeadChip arrays, which simultaneously quantify methylation at ~2% of all CpG
dinucleotides in the human genome. The RHM samples were from women with a variety of
genetic lesions including siblings carrying the same homozygous non-synonymous missense
mutation (c. 2078G>C; p.R693P), an individual homozygous for a deletion that removes exons
2–5 (c.-39-1769_2129+228del) and a female with compound heterozygous mutations
(c.2018C>G, c.2161C>T; p.S673X, p.R721W) (Fig 1A). Our initial analysis focused on com-
paring the methylation profiles of four androgenetic moles and seven normal placental samples
(three first trimester and four third trimester) with those obtained for the NLRP7-mutated
samples (Fig 1B and S1A Fig). A total of 616 probes mapping to 36 known ubiquitous
imprinted DMRs were assessed, with observations confirmed by both pyrosequencing and
standard allele-specific bisulphite PCR and sub-cloning (Fig 1C, S1C and S2 Figs). These com-
prehensive analyses revealed that, while normal placental biopsies had partial methylation con-
sistent with allelic methylation (with the exception of the fully methylated NNAT and GNAS-
AS1 promoters) [18], the majority of maternally methylated DMRs presented with lack-of-
methylation (LOM) in both androgenetic and NLRP7-associated HMs. The only exceptions
were for the IGF1R and RB1 DMRs that maintain allelic methylation in both types of mole,
whereas the SNURF DMR was maintained in some of the NLRP7-mutated samples. In addi-
tion, we observe some inter-individual differences. The FAM50B DMRmaintained a partially
methylated state in two androgenetic CHMs and in a RHM from one of the sisters with the
NLRP7 p.R693P mutation. Surprisingly, this same RHM sample also showed imprinted meth-
ylation at the PLAGL1 and PEG10 DMRs (Fig 1C and S2 Fig). Furthermore a comparison of
two different RHMs from patient 4 revealed a similar methylation profile with the exception
that the PEG10 and SNURF DMRs presented allelic methylation in one of the moles (S1 Fig).
The PEG10DMR was previously reported to be largely unaffected in three familial RHM sam-
ples [14]. The only paternal DMR with probes present on this array that acquires methylation
in the male germline and is partially methylated in placenta is theH19 DMR (also known as
ICR1). Consistent with the two copies of the sperm genome, the androgenetic CHMs are fully
methylated at this locus, whereas the RHM are partially methylated. In 3 cases allele-specific
bisulphite PCR revealed that the methylation was on the paternal allele (Fig 1C). Quantitative
pyrosequencing of bisulphite PCRs targeting the IG-DMR on chromosome 14, which also
Methylation Profiling of NLRP7Moles
PLOS Genetics | DOI:10.1371/journal.pgen.1005644 November 6, 2015 3 / 17
Fig 1. Description ofNLRP7mutations with methylation and expression profiling of imprinted loci. (A) Confirmation of recessiveNLRP7mutations in
female patients and heterozygous status in the RHM samples. The asterisk (*) on the electropherogram highlights the position of the mutation. For patient 3
the position of the deletion is shown. (B) Circular heat map of the 616 Infinium array probes mapping to 36 ubiquitously imprinted DMRs. The inner circle
represents the methylation values of androgenetic HMs, the middle circles normal placental biopsies and the outer circle the RHMs associated with maternal-
effectNLRP7mutations. (C) Confirmation of the methylation profile of theNLRP7mutated RHMs at theNAP1L5, PEG10, RB1, L3MBTL1 andH19 DMRs by
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acquires methylation from sperm but does not have probes on the HM450k array platform,
revealed a partially methylated profile in both control placenta and RHMs (S2 Fig). Similarly
theMEG3DMR, which is regulated in-cis by the IG-DMR, shows a similar partially methylated
profile consistent with allelic methylation (Fig 1B). The ZBDF2 and ZNF597/NAA60 promoters
were fully methylated in both androgenetic CHM and NLRP7mutated RHMs. This is consis-
tent with the presumption that these regions acquire methylation on the paternal allele during
early development under the hierarchical influence of the maternally methylated GPR1-AS and
ZNF597 DMRs, respectively [18].
To determine if the lack of methylation at imprinted DMRs results in altered expression we
performed allelic-specific RT-PCR on the RHM samples. We confirm thatHYMAI, PEG10
and PEG3 transcripts are paternally expressed in control placenta samples but expressed from
both alleles in RHMs (Fig 1D). Biallelic expression of NAP1L5 was associated with LOM in
RHM1, but imprinted expression was preserved in RHM3 that had allelic methylation at this
DMR (Fig 1C and 1D).
Widespread absence-of-methylation at placenta-specific imprinted loci
Recently, using genome-wide methylation profiling in normal placental biopsies and androge-
netic moles, we identified 18 placenta-specific maternally methylated DMRs [18]. Genome-
wide methylation analysis utilizing methyl-seq in human gametes revealed that these loci
inherit methylation from oocytes and maintain allelic methylation during pre-implantation
reprograming [19]. We interrogated the 153 probes mapping to these placenta-specific
imprinted DMRs and confirmed observations by both pyrosequencing and allele-specific bisul-
phite PCR (Fig 2, S1 and S2 Figs). This revealed that, while first trimester and term placental
biopsies had partial methylation indicative of maternally methylated DMRs, all androgenetic
and NLRP7-associated HMs presented with robust LOM. In several cases the RHM samples
were heterozygous for single base pair polymorphisms (SNPs) that confirmed that methylation
was absent from the maternal alleles (Fig 2B). Consistent with the lack of allelic methylation,
the normally paternally expressed imprinted genesMCCC1, LIN28B and GLIS3 are expressed
from both parental alleles in RHMs (Fig 2C). Furthermore qRT-PCR revealed an increased
expression of DNMT1 and AGBL3 compared to normal placenta samples coherent with bialle-
lic over-expression. Expression was within the normal range for H19 which in consistent with
the maintained paternally derived methylation at this DMR (Fig 2D). Furthermore, our previ-
ous results revealed that approximately 12% of all CpG methylation is contained within LINE-
1 sequences [20]. Pyrosequencing analysis of these retrotransposable elements, as well as α-sat-
ellites and Alu-Yb8 sequences, in NLRP7-mutated RHMs revealed a profile indistinguishable
from normal placenta (S3 Fig) [18]. Together these observations suggest that only maternally
derived methylation is affected in RHM, consistent with oocyte epigenetic aberration and not
somatic imprint maintenance.
Identification of novel maternal methylated regions in human placenta
To expand our methylation analysis we performed an unbiased screen for additional loci with
abnormal methylation in the RHM samples with underlying NLRP7mutations. The identified
regions were characterized by at least 3 Infinium probes and relative distance between consecu-
tive probes below 500 bp, requiring runs with a consistent change (same direction and p-
bisulphite PCR and subcloning. Each circle represents a single CpG dinucleotide on a DNA strand, a methylated cytosine (●) or an unmethylated cytosine
(○). For clarity, only the first 10 CpG dinucleotides from each amplicon are shown with the letters in the parentheses indicating SNP genotype. (D) Allelic
expression analysis of imprinted genesNAP1L5, HYMAI, PEG10 and PEG3 in control placenta samples (PL) andNLRP7-mutated moles (RHM).
doi:10.1371/journal.pgen.1005644.g001
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Fig 2. Methylation and expression analyses of placenta-specific DMRs in RHM samples. (A) Circular heatmap of the 153 Infinium array probes
mapping to the 18 known placenta-specific imprinted DMRs. The inner circles represent the methylation values of androgenetic HMs, the middle circles
normal placental biopsies and the outer circle the RHMs associated with maternal-effectNLRP7mutations. (B) Confirmation of the methylation profile at the
maternally methylatedGLIS3, DNMT1 andMCCC1DMRs by bisulphite PCR and subcloning. Each circle represents a single CpG dinucleotide on a DNA
strand, a methylated cytosine (●) or an unmethylated cytosine (○). For clarity, only the first 10 CpG dinucleotides from each amplicon are shown with the
Methylation Profiling of NLRP7Moles
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value< 0.01) and an absolute average methylation change>20% (β 0.2). This analysis identi-
fied 61 regions, 56 of which are CpG islands, 88% mapping to transcript promoters (Fig 3A; S1
Table). Surprisingly all candidate regions identified were partially methylated in normal pla-
cental biopsies and devoid of methylation in androgenetic CHMs and somatic tissues (Fig 3A;
S1 Table). This profile suggests the existence of further placenta-specific maternally methylated
regions that could regulate imprinted expression. Consistent with the regions being maternally
methylated, all regions were unmethylated in sperm (S1 Table). To confirm if the observed
methylation was restricted to the maternal allele we developed a methylation-sensitive geno-
typing assay in which polymorphic allele calling is performed on genomic DNA before and fol-
lowing digestion with the methylation-sensitive HpaII endonuclease (Fig 3B). Allelic
methylation is confirmed when a heterozygous genomic DNA sample is reduced to homozy-
gosity following digestion with the remaining allele representing the methylated chromosome.
Twenty-eight of the 61 candidate regions had highly informative SNPs that allowed parental
origin of methylation to be determined. In 22 cases we confirmed the presence of maternal
methylation in multiple placenta samples, with a further six regions being allelically methylated
with parental genotypes being uninformative (Fig 3C and 3D, S4 and S5 Figs; S2 Table). Fifteen
of these samples were subsequently shown to be allelically methylated using bisulphite PCR
and subcloning with an additional five regions associated with RHOBTB3, PURA, FGF8,
CCDC71L andWIF1 presenting with both fully methylated and unmethylated DNA strands
(Fig 3D and S5 Fig).
Allelic expression analysis reveals additional imprinted genes in the
human placenta
The main biological significance of allele-specific methylation is allele-specific RNA expres-
sion, which in the case of maternally methylated regions is predicted to dictate paternal expres-
sion. We subsequently determined allelic expression for a subset of transcripts that contained
highly polymorphic exonic SNPs. Allele-specific RT-PCR confirmed paternal expression of
RHOBTB3, SCIN, ZNF396, ST8SIA1, ZFP90, CCDC71L, RASGRF1,HECW1 and CMTM3 with
monoallelic expression of CD83 in a polymorphic fashion in multiple placental biopsies (Fig
4A and S6A Fig; S3 Table). In situations where monoallelic expression was uninformative due
to maternal DNA also being heterozygous, the methylated allele was always the repressed one,
suggesting a functional link between methylation and expression. In addition, we identified a
maternally methylated CpG islands overlapping the promoter of SNCB, a transcript that has
previously been described as paternally expressed in placenta [21]. Furthermore, we also identi-
fied a maternal DMR within the TTC39A gene that is adjacent to EPS15, a transcript also
reported to be imprinted in placenta [22] (S5 Fig).
To determine whether these placenta-specific DMRs can orchestrate allelic silencing of gene
clusters similar to ubiquitous imprinted DMRs, we performed allele-specific RT-PCR for 20
flanking genes associated with loci containing imprinted transcripts (Fig 4B and S6B Fig). Sur-
prisingly, with the exception of ADAM23 within the GPR1-AS domain on chromosome 2, we
observe that the remaining 19 transcripts analyzed are expressed equally from both parental
chromosomes, indicating that placenta-specific DMRs do not possess the ability to regulate
allelic expression of surrounding genes. Despite evolutionary conserved imprinting of
GPR1-AS and ZDBF2 [23], paternal expression of ADAM23 is not observed in mouse placenta
letters in the parentheses indicating SNP genotype. (C) Allelic expression analysis of imprinted genesMCCC1, LIN28B andGLIS3 in control placenta
samples (PL) andNLRP7-mutated moles (RHM). (D) Quantitative RT-PCR for H19, DNMT1 and AGBL3 in RHM samples. The boxplot show the median
expression (whiskers 5–95% percentile) determined for 15 control placenta samples with the values of RHMs highlighted.
doi:10.1371/journal.pgen.1005644.g002
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Fig 3. Identification of additional placenta-specific imprinted DMRs in RHM samples. (A) A heatmap for the βmean of the Infinium probes with a
methylation difference (>20%, minimum 3 consecutive probes) in RHMs associated with maternal effectNLRP7mutations compared to control placental
biopsies. (B) Schematic representation of the methylation-sensitive HpaII genotyping assay. (C) Methylation profiles as determined by methylation-sensitive
genotyping and (D) bisulfite PCR and subcloning on placenta and somatic tissue DNA samples at the SCIN, ST8AIA1 andCABIN1 promoters. Note that the
samples used for methylation-sensitive genotyping and bisulphite PCRmaybe different to highlight that methylation is not associated with genotype but
parental origin.
doi:10.1371/journal.pgen.1005644.g003
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Fig 4. Allele-specific RT-PCR analysis of candidate placenta-specific imprinted genes. (A) Confirmation of paternal expression of RHOBTB3, SCIN and
ZNF396 in term placenta and biallelic expression of neighboring genes. (B) The allele-specific expression analysis of genes flanking known placenta-specific
imprinted transcriptsGPR1-AS,MCCC1 and AGBL3. Biallelic expression of ZNF396, ADAM23,MCCC1 and AGBL3was confirmed in somatic tissues. (C)
Allele-specific RT-PCR analysis of Adam23 in mouse embryo and placenta at embryonic day 9.5. The asterisk (*) in the sequence traces shows the position
of the polymorphic base. The blue boxes in the figures represent the paternally expressed transcripts, white boxes signify biallelically expressed genes and
grey boxes are transcripts not expressed in term placenta samples. The location of unmethylated CpG islands and the DMRs are shown by the lollipops.
PL = placenta, BR = brain, KID = kidney, LY = blood leucocytes, CB = cord blood.
doi:10.1371/journal.pgen.1005644.g004
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(Fig 4C). Together this suggests that this locus is regulated in a different manner to the majority
of placenta-specific imprinted loci identified and that subtle species differences exist [24].
Discussion
We have compared the DNA methylation profiles of RHMs with underlying NLRP7mutations
with androgenetic CHM biopsies. This has revealed not only widespread methylation defects at
imprinted loci, but has facilitated in the identification of novel maternally methylated loci. As a
result of unbiased bioinformatic analyses, the number of genes associated with placenta-spe-
cific maternally methylated DMRs has increased from 18 to 43, with a further eight regions of
allelic methylation indicative of an imprinted DMR. In addition, a further 28 candidates did
not contain SNP allowing allelic methylation to be determined. Our observations indicate that
there are more imprinted domains in the human placenta than in somatic tissues. Interestingly,
10 of these loci (TMEM17, NUDT12, RHOBTB3, CD83, ARMC3, AIFM2, ST8SIA1, PCK2,
RASGRF1, CMTM3) show opposing methylation profiles in diandric (two paternal plus one
maternal haploid genomes) compared to digynic (extra maternal chromosomes) triploid biop-
sies [25], consistent with the maternal methylation profile we describe.
It is currently unknown which imprinted genes are responsible for the HM phenotype, but
aberrant expression from the maternal allele of these placenta-specific genes is likely to play an
important role, since they include the essential epigenetic gene DNMT1 and the micro-RNA
processor LIN28B. In addition there are several strong candidates for influencing trophoblast
development, including the cytochrome P450 (CYP) subfamily member CYP2J2 that has previ-
ously been shown to be up-regulated in preeclampsia and THSD7A, a placental and endothelial
protein that mediates cellular migration [26, 27]. In addition, the deregulation and over-
expression of the C19MC pri-miRNA will lead to the concomitant increased abundance of 50
mature miRNAs that have recently been shown to regulate trophoblast invasion [28, 29].
Our genome-wide analysis revealed aberrant methylation profiles in RHM associated with
maternal-effect NLRP7 defects at imprinted loci. It is not possible to determine if the methyla-
tion anomalies are restricted to imprinted loci, as many regions inheriting methylation from
oocytes undergo epigenetic reprograming during pre-implantation development [30, 31],
resulting in an unmethylated state that is indistinguishable from an epimutation. Similar epige-
netic profiling of blood-derived DNA from the women carrying biallelic recessive genetic
mutations of NLRP7 failed to identify any methylation anomalies when compared to healthy
controls (S7 Fig), endorsing the hypothesis that the methylation defect arises by maternal-effect
either in the developing oocyte or in early pre-implantation stages. Our results imply that the
epigenetic aberration observed in RHM arise early in the female germline since paternally
methylated DMRs are unaffected, maintaining the correct methylation profiles at theH19 and
IG-DMR loci. This suggests that NLRP7 has a different function to ZFP57 [32] or DPPA3 [33],
which both protect multiple imprints from TET3-associated 5mC to 5hmC reprogramming at
the zygotic stage when the pronuclei have yet to breakdown and the parental genomes fuse
[34]. Endorsing this theory, detailed immunostaining for NLRP7 in early human embryos
revealed that this protein is exclusively localized to the cytosekeleton and not in the nucleus
where it could associate with chromatin and influence methylation [11]. In addition, NLRP7 is
not observed in the nucleus of developing oocytes (germinal vesicle (GV) stage oocytes through
to those arrested in metaphase II) [5, 11]. Curiously, immunostaining for the de novomethyla-
transferases DNMT3A and DNMT3B revealed a similar cytoplasmic localization [35], indicat-
ing that a NLRP7-complex may ensure the correct cellular localization and nuclear
translocation of these epigenetic factors during a yet to be identified period of oocyte develop-
ment. Once in the nucleus, this low abundance complex may associate to specific DNA
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sequences by direct interaction with chromatin regulator YY1 or ZBTB16 [36, 37]. This, and
the absence of DNMT3L in human GV-metaphase II oocytes, highlights the fact that the pro-
cess of imprint acquisition in humans and mouse differ greatly.
The NLRP family of proteins is known to play a direct role in inflammasome activation,
which results in the secretion of interleukin-1β (IL-1β) [38]. These observations offer an indi-
rect mechanism explaining how NLRP7 influences maternally derived methylation. Prenatal
oogenesis produces hundreds of thousands of oocytes, most of which are discarded before
birth. During fetal development this phenomenon is associated with oocyte apoptosis, acting as
a quality control measure, eliminating cells with meiotic anomalies. Interestingly, strong
NLRP7 staining has been reported in human blastomeres undergoing apoptosis [11]. The pro-
cess of oocyte selection can be influenced by pro-survival factor IL-1β, a cytokine known to be
involved in oocyte nuclear maturation in many mammalian species [39]. This reduction in
oocyte number occurs at the approximate time (14–20 weeks gestation) when they presumably
acquire the methylation signatures at imprinted regions [40]. It is therefore plausible that dis-
ruption to the selection mechanism through defective NLRP7 may allow for the survival, and
eventual dominant follicle recruitment, ovulation and fertilization decades later, of an oocyte
with an inappropriate methylation state. Whatever the underlying mechanism, we show that
maternal-effect mutations of NLRP7 are associated with the most severe cases of multi-locus
imprinting defects in humans.
Material and Methods
Ethics statement
All women had presented with multiple RHMs (patients 1–4 had 3, 6, 4 and 3 previous RHMs,
respectively) and provided informed consent to use their tissues for research. The ethical
approval was granted by the Bellvitge Institute for Biomedical Research (PR096/10) and the
Tissue Management Committee of the Imperial College Healthcare NHS Trust Research Tissue
Bank (R15048), which is approved by NRES to provide deemed ethics for projects accessing
material and data stored within the Research Tissue Bank. All mothers provided informed con-
sent for themselves and their child prior to participating in the study. Ethical approval for col-
lecting blood and placental samples was granted by the ethical committees of Hospital St Joan
De Deu Ethics Committee (Study number 35/07), Bellvitge Institute for Biomedical Research
(PR006/08) and the National Center for Child Health and Development (project 234). Periph-
eral blood samples were obtained from healthy volunteers and tissue samples were obtained
from BrainNet Europe/Barcelona tissue bank. Mouse work was approved by the Institutional
Review Board Committees at the National Center for Child Health and Development (approval
number A2010-002). Animal husbandry and breeding were conducted according to the institu-
tional guidelines for the care and the use of laboratory animals.
Patient samples
Five molar biopsies from four different women with two mutated copies of the NLRP7 gene
who were referred to the Trophoblastic Tumour Screening and Treatment Centre, Charing
Cross Hospital (London, UK) were used in this study. The mutations were identified using
standard PCR and sequencing as previously described [5]. All women had presented with mul-
tiple RHMs and provided informed consent to use their tissues for research.
A cohort of 72 human placenta biopsies with corresponding maternal blood samples were
collected at Hospital St Joan De Deu (Barcelona, Spain) and the National Center for Child
Health and Development (Tokyo, Japan). All placenta biopsies were collected from the fetal
side around the cord insertion site. The placenta-derived DNA samples were free of maternal
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DNA contamination based on microsatellite repeat analysis. Both DNA and RNA extractions
and cDNA synthesis were carried out as previously described [20, 41].
Mouse crosses
Wild type mouse embryos and placentae were produced by crossing C57BL/6 (B) withMus
musculus molosinus (JF1) mice and collected at embryonic day 9.5.
Methylation array hybridisation
We generated methylation datasets using the Illumina Infinium HumanMethylation450 Bead-
Chip arrays, which simultaneously quantifies ~2% of all CpG dinucleotides. Bisulphite conver-
sion of 600 ng of DNA was performed according to the manufacturer’s recommendations for
the Illumina Infinium Assay (EZ DNAmethylation kit, ZYMO, Orange, CA). The bisulphite-
converted DNA was used for hybridisation following the Illumina Infinium HDmethylation
protocol at genomic facilities of the Cancer Epigenetics and Biology Program (Barcelona,
Spain) or the Barts and The London School of Medicine and Dentistry Genome Centre (Lon-
don, UK). The resulting data for the NLRP7-mutated familial RHMs and the corresponding
maternal blood samples have been deposited in the GEO database with the accession number
GSE66247. In addition we used the androgenetic CHMs, control placenta and leukocyte data-
sets from GSE52576.
Data filtering and analysis
Before analysing the data, we excluded possible sources of technical biases that could influence
results. We applied signal background subtraction and inter-plate variation was normalized
using default control probes in BeadStudio (version 2011.1_Infinium HD). We discarded
probes with a detection p-value>0.01. We also excluded probes that lack signal values in one
or more of the DNA samples analysed. For the analysis of known imprinted domains, probes
mapping to the DMRs identified by Court and colleagues were directly analysed. Prior to
screening for novel imprinted DMRs we excluded all X chromosome CpG sites. An in-house
bioinformatic pipeline (using R-package) was utilized to tests the difference of a minimum of 3
consecutive Infinium probes within 500bp windows via a linear model (empirical Bayes mod-
erated p-value< 0.01) that provides a t-statistic, with an absolute methylation change
of> 20% (beta 0.2). The circular heatmaps used to display the DNAmethylation profiles were
generated using Circos software.
Genotyping and imprinting analysis
Genotypes of potential SNPs identified in the UCSC hg19 browser were obtained by PCR and
direct sequencing. Sequence traces were interrogated using Sequencher v4.6 (Gene Codes Cor-
poration, MI) to distinguish heterozygous and homozygous samples. Heterozygous sample sets
were analyzed for either allelic expression using RT-PCR, methylation-sensitive genotyping or
bisulphite PCR, incorporating the polymorphism within the final PCR amplicon so that paren-
tal alleles could be distinguished (for primer sequence see S4 Table).
Quantitative RT-PCR
Expression of the transcripts of interest was analyzed by quantitative real-time RT-PCR with a
fluorochrome (SYBR Green) assay and normalized against RPL19. Primer sequences are listed
in S4 Table. The assays were run in triplicate in 384 well plates in 7900HT Fast Real Time PCR
System (Applied Biosystems). Dissociation curves were obtained at the end of each reaction to
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rule out the presence of primer dimers oabbrevr unexpected DNA species in the reaction.
Non-template controls and a calibrator cDNA were included in each assay. Results were ana-
lyzed with the SDS 2.3 software (Applied Biosystems). Data analysis was performed using the
RQ method and final graphs generated in prism5.
Bisulphite PCR
Approximately 1 μg DNA was subjected to sodium bisulphite treatment and purified using the
EZ DNAmethylation-Gold kit (ZYMO, Orange, CA) and was used for all bisulphite PCR anal-
ysis. Approximately 2 ul of bisulphite converted DNA was used in each amplification reaction
using Immolase Taq polymerase (Bioline) at 45 cycles and the resulting PCR product cloned
into pGEM-T easy vector (Promega) for subsequent subcloning and sequencing (for primer
sequence see S4 Table).
Pyrosequencing analysis for methylation quantification
Approximately 50 ng of bisulphite converted DNA was used for pyrosequencing. Standard
bisulphite PCR was used to amplify the imprinted DMRs with the exception that one primer
was biotinylated (see S4 Table for primer sequences). Previously published primers targeting
LINE-1, α-satellites and ALU-Yb8 were used for amplification and sequencing [20]. In all cases
the entire biotinylated PCR product (diluted to 40 μl) was mixed with 38 μl of Binding buffer
and 2 μl (10 mg/ml) streptavidin-coated polystyrene beads. After washing in 70% ethanol,
DNA was denaturated with 50 μl 0.5M NaOH. The single-stranded DNA was hybridized to
40-pmol sequencing primers dissolved in 11 μl annealing buffer at 80°C. For sequencing, for-
ward primers were designed to the complementary strand. The pyrosequencing reaction was
carried out on a PyroMark Q96 instrument. The peak heights were determined using Pyro
Q-CpG1.0.9 software (Biotage).
Methylation-sensitive genotyping
Approximately 500 ng of heterozygous genomic DNA was digested with 10 units ofHpaII
restriction endonuclease for 4 hours at 7°C. The digested DNA was subject to ethanol precipi-
tation and resuspended in a final volume of 20 μl TE or water. Approximately 2 μl of digested
DNA was used in each amplification reaction using Bioline Taq polymerase for 40 cycles. The
resulting amplicons were sequenced and the sequences traces compared to those obtained for
the corresponding undigested DNA template.
Accession numbers
The Illumina Infinium HumanMethylation450 BeadChip array data has been deposited in the
GEO repository and assigned the accession number GSE66247 and GSE52576.
Supporting Information
S1 Fig. Comparison of imprinted methylation profiles in two different RHMs from patient
4. (A) Heatmap of the Infinium probes located within known imprinted DMRs. (B) Heatmap
for the Infinium probes mapping to known placenta-specific DMRs. The methylation profiles
were confirmed using pyrosequencing for ubiquitous DMRs (C) and placenta-specific DMRs
(D). Bisulphite PCR and subcloning confirmation of the methylation difference observed
between mole 4 and 4.2 at the PEG10 DMR. Each circle represents a single CpG dinucleotide
on a DNA strand, a methylated cytosine (●) or an unmethylated cytosine (○).
(PDF)
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S2 Fig. Methylation profiles of four NLRP7 mutated RHMs at imprinted DMRs as deter-
mined by pyrosequencing and bisulphite PCR and subcloning. (A) Quantitative pyrose-
quencing of 16 ubiquitous DMRs and (B) 9 placenta-specific DMRs. The boxplot showing the
median methylation (whiskers 5–95% percentile) determined for 15 control placenta samples
and the values of RHMs highlighted as shaded circles. (C) Confirmation of the lack-of-methyl-
ation at imprinted DMRs by bisulphite PCR and subcloning. Each circle represents a single
CpG dinucleotide on a DNA strand, a methylated cytosine (●) or an unmethylated cytosine
(○). (D) Cloning for known placenta-specific DMRs.
(PDF)
S3 Fig. Quantification of methylation at repeat elements using pyrosequencing. The box-
plot showing the median methylation (whiskers 5–95% percentile) determined for 15 control
placenta samples and the values of RHMs highlighted.
(PDF)
S4 Fig. Confirmation of maternal methylation in term placenta biopsies. The allelic methyl-
ation profiles as determined by methylation-sensitiveHpaII genotyping in placenta for 18 can-
didate regions. The asterisk () in the sequence traces shows the position of the polymorphic
base. The locations of the PCR amplicon are shown for each region.
(PDF)
S5 Fig. Strand-specific bisulphite PCR and sequencing of novel placenta-specific DMRs in
term placenta biopies. Confirmation of the strand-specific and allelic methylation at seven
candidate DMRs associated with the TTC39A/EPS15, THAP3, EGR4 RPN1, RHOBTB3, PURA,
SNCB, THSD7A, CCDC71L, ARMC3, AIFM2, FGF8, CYB5R2, RNF141,WIF1, RASGRF1 and
SIAH1 genes by bisulphite PCR and subcloning. Each circle represents a single CpG dinucleo-
tide on a DNA strand, a methylated cytosine (●) or an unmethylated cytosine (○) with the let-
ters in the parentheses indicating SNP genotype. The locations of the PCR amplicon are shown
for each region.
(PDF)
S6 Fig. Allele-specific RT-PCR analysis of candidate placenta-specific imprinted genes. (A)
Confirmation of monoallelic expression of CD83 and paternal expression ofHECW1,
CCDC71L, ST8SIA1, RASGRF1, CMTM3 and ZFP90 in term placenta samples. (B) The allele-
specific expression analysis of genes flanking known placenta-specific imprinted transcripts.
The asterisk () in the sequence traces shows the position of the polymorphic base. Biallelic
expression of GLIS3, ZC3H12C and DNMT1 was also observed in adult somatic tissues.
PL = placenta, BR = Brain, KID = Kidney, LY = blood leucocytes.
(PDF)
S7 Fig. Genome-wide methylation analysis in blood-derived DNA samples from the four
females with recessive NLRP7mutations. A heatmap of the Infinium probes located within
known imprinted DMRs. As controls for allelic methylation, the profiles of reciprocal unipa-
rental diploidy and four control blood samples are shown.
(PDF)
S1 Table. Infinium probe IDs and β values at known and candidate regions. The methyla-
tion β values for each of the probes within (A) ubiquitous and (B) known placenta-specific
imprinted DMRs. (C) A list of probes, with their corresponding methylation β values, located
in candidate imprinted DMRs revealed by the comparison of Infinium methylation profiles of
NLRP7mutated RHM samples, control placenta and various somatic tissues. (D) The methyla-
tion β values for each probe within ubiquitous DMRs for blood-derived DNA from the
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homozygous NLRP7mutated mothers. Each table includes the unique probe ID, map informa-
tion and corresponding gene name.
(XLSX)
S2 Table. The number of heterozygous placenta samples used to determine allelic methyla-
tion of novel DMRs usingHpaII genotyping.
(DOCX)
S3 Table. The number of heterozygous placenta samples used to determine allelic expres-
sion of novel imprinted transcripts.
(DOCX)
S4 Table. PCR primer sequences used in this study.
(XLSX)
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